Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL

Clinical trial NCT06803693 · RECRUITING

Trial details

NCT number: NCT06803693
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma

Start date: 2025-04-01
Primary completion: 2028-04-30
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.